Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut

Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

More In Business

Big Business This Week: Can global prosperity survive a ‘Doom Loop’?

Have we seen the end of 80 years of increasing global prosperity and relative peace?

Markets React to Fed Decision, What Happens Next?

Fed’s latest rate decision shakes markets; Nathan Sheets of Citigroup breaks down impacts on growth, inflation, labor, investor sentiment, and policy risks.

From Self-Checkout to Smart Stores: The Tech Powering Modern Retail

Jim Kelly, CEO of NCR Voyix, on how the 100-year-old company powers $1.4T in transactions and keeps reinventing retail, restaurants, and payments.

The Best and Worst Airlines of 2025: You Won’t Believe Who Came Out on Top

Allison Pohle, reporter at The Wall Street Journal, breaks down airline chaos, surprise winners, and what the latest rankings mean for your next flight.

Ducati Celebrates a Century of Racing While Gearing Up for the Future

Jason Chinnock discusses Ducati’s 100th anniversary, blending a century of racing heritage with innovation, off-road expansion, and plans for the next 100 years

Beyond Ozempic: Why Silicon Valley Is Turning to Experimental Peptides

Jasmine Sun on unregulated peptides moving from fringe biohacking to Silicon Valley mainstream, promising healing, focus, and optimization with little oversight

Load More